| Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study M Magid, JS Reichenberg, PE Poth, HT Robertson, AK LaViolette, ... The Journal of clinical psychiatry 75 (8), 21521, 2014 | 159 | 2014 |
| Electroconvulsive and neuromodulation therapies CM Swartz Cambridge University Press, 2009 | 132 | 2009 |
| Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials M Magid, E Finzi, THC Kruger, HT Robertson, BH Keeling, S Jung, ... Pharmacopsychiatry 25 (06), 205-210, 2015 | 74 | 2015 |
| Psychocutaneous disease: clinical perspectives H Kuhn, C Mennella, M Magid, C Stamu-O’Brien, G Kroumpouzos Journal of the American Academy of Dermatology 76 (5), 779-791, 2017 | 69 | 2017 |
| Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial MA Wollmer, N Kalak, S Jung, C de Boer, M Magid, JS Reichenberg, ... Frontiers in Psychiatry 5, 36, 2014 | 55 | 2014 |
| Botulinum toxin for depression: Does patient appearance matter? JS Reichenberg, AJ Hauptman, HT Robertson, E Finzi, THC Kruger, ... Journal of the American Academy of Dermatology 74 (1), 171-173. e1, 2016 | 42 | 2016 |
| Practical psychodermatology A Bewley, RE Taylor, JS Reichenberg, M Magid John Wiley & Sons, 2014 | 42 | 2014 |
| Trichotillomania M Huynh, AC Gavino, M Magid , 32, 2 32 (2), 88-94, 2013 | 40 | 2013 |
| Use of electroconvulsive therapy in a patient 10 days after myocardial infarction M Magid, MI Lapid, SM Sampson, PS Mueller The Journal of ECT 21 (3), 182-185, 2005 | 38 | 2005 |
| Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis J Schulze, I Neumann, M Magid, E Finzi, C Sinke, MA Wollmer, ... Journal of psychiatric research 135, 332-340, 2021 | 33 | 2021 |
| Onychophagia and onychotillomania can be effectively managed M Magid, C Mennella, H Kuhn, C Stamu-O'Brien, G Kroumpouzos Journal of the American Academy of Dermatology 77 (5), e143-e144, 2017 | 30 | 2017 |
| Psychocutaneous disease: pharmacotherapy and psychotherapy H Kuhn, C Mennella, M Magid, C Stamu-O’Brien, G Kroumpouzos Journal of the American Academy of Dermatology 76 (5), 795-808, 2017 | 28 | 2017 |
| Patients labeled with delusions of parasitosis compose a heterogenous group: a retrospective study from a referral center JS Reichenberg, M Magid, CA Jesser, CS Hall Journal of the American Academy of Dermatology 68 (1), 41-46. e2, 2013 | 27 | 2013 |
| Habit reversal training for body-focused repetitive behaviors: a practical guide for the dermatologist. AB Dunbar, M Magid, JS Reichenberg Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa …, 2018 | 21 | 2018 |
| No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis BE Strober, RGB Langley, A Menter, M Magid, B Porter, T Fox, J Safi Jr, ... British Journal of Dermatology 178 (2), e105-e107, 2018 | 17 | 2018 |
| Neurotoxins: expanding uses of neuromodulators in medicine—major depressive disorder M Magid, BH Keeling, JS Reichenberg Plastic and Reconstructive Surgery 136 (5S), 111S-119S, 2015 | 17 | 2015 |
| Approach to a psychodermatology patient. JS Reichenberg, G Kroumpouzos, M Magid Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa …, 2018 | 15 | 2018 |
| Successful treatment of patients previously labeled as having" delusions of parasitosis" with antidepressant therapy. A Delacerda, JS Reichenberg, M Magid Journal of Drugs in Dermatology: JDD 11 (12), 1506-1507, 2012 | 15 | 2012 |
| Botulinum toxin for depression? An idea that’s raising some eyebrows M Magid, J Reichenberg Curr. Psychiatr 14, 43-56, 2015 | 14 | 2015 |
| Emergency ECT in an incapacitated, medically compromised patient with Huntington’s disease M Magid, K Trevino, WH Reid, S Jalalat, MM Husain, DA Kahn Journal of Psychiatric Practice® 20 (6), 470-475, 2014 | 14 | 2014 |
